Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes
MicroRNAs (miRNAs) are short non-coding RNAs that regulate the function of target genes at the post-transcriptional phase. miRNAs are considered to have roles in the development, progression and metastasis of cancer. Recent studies have indicated that particular miRNA signatures are correlated with...
Gespeichert in:
Veröffentlicht in: | Journal of human genetics 2017-01, Vol.62 (1), p.15-24 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 24 |
---|---|
container_issue | 1 |
container_start_page | 15 |
container_title | Journal of human genetics |
container_volume | 62 |
creator | Kurozumi, Sasagu Yamaguchi, Yuri Kurosumi, Masafumi Ohira, Miki Matsumoto, Hiroshi Horiguchi, Jun |
description | MicroRNAs (miRNAs) are short non-coding RNAs that regulate the function of target genes at the post-transcriptional phase. miRNAs are considered to have roles in the development, progression and metastasis of cancer. Recent studies have indicated that particular miRNA signatures are correlated with tumor aggressiveness, response to drug therapy and patient outcome in breast cancer. On the other hand, in routine clinical practice, the treatment regimens for breast cancer are determined based on the intrinsic subtype of the primary tumor. Previous studies have shown that miRNA expression profiles of each intrinsic subtypes of breast cancer differ. In hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, miRNA expressions are found to be correlated with endocrine therapy resistance, progesterone receptor expression and heat shock protein activity. Some miRNAs are associated with resistance to HER2-targeted therapy and HER3 expression in HER2-positive breast cancer. In triple-negative breast cancer, miRNA expressions are found to be associated with BRCA mutations, immune system, epithelial-mesenchymal transition, cancer stem cell properties and androgen receptor expression. As it has been clarified that the expression levels and functions of miRNA differ among the various subtypes of breast cancer, and it is necessary to take account of the characteristics of each breast cancer subtype during research into the roles of miRNA in breast cancer. In addition, the discovery of the roles played by miRNAs in breast cancer might provide new opportunities for the development of novel strategies for diagnosing and treating breast cancer. |
doi_str_mv | 10.1038/jhg.2016.89 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1859474845</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1826723540</sourcerecordid><originalsourceid>FETCH-LOGICAL-c387t-e08af1909edeb5387c4ba5d3a503ec6f0d5ecb1b31559247555bcb5ebd61db1d3</originalsourceid><addsrcrecordid>eNqNkU1LHEEQhptgiMbklLs0eAnIrP05M30UMSYgBiSB3Ib-qMn2stu9dvUg_oP8bGfVJODJUxUvDw9UvYR84mzBmexPV8vfC8F4u-jNG3LAldSNkOLX3uOuGs1bvk_eI64YY1J04h3ZF52Spu3FAflzAx5SpbVACkhjopvoS765PqMFEGzxyzmsmboCFiv1Nnko9C7WJd3aUqOf1rbQMfsJaU60LoFaxOyjrTEnpA7qHcB_LVKbwk5ZYsLoKU6u3m8BP5C3o10jfHyeh-Tnl4sf51-bq--X387Prhov-642wHo7csMMBHB6jrxyVgdpNZPg25EFDd5xJ7nWRqhOa-280-BCy4PjQR6Sz0_ebcm3E2AdNhE9rNc2QZ5w4L02qlO90q9ARdsJqRWb0eMX6CpPJc2H7IRacm6MmKmTJ2p-BWKBcdiWuLHlfuBs2HU5zF0Ouy6H3sz00bNzchsI_9i_5ckHjS2cOg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1855311992</pqid></control><display><type>article</type><title>Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Kurozumi, Sasagu ; Yamaguchi, Yuri ; Kurosumi, Masafumi ; Ohira, Miki ; Matsumoto, Hiroshi ; Horiguchi, Jun</creator><creatorcontrib>Kurozumi, Sasagu ; Yamaguchi, Yuri ; Kurosumi, Masafumi ; Ohira, Miki ; Matsumoto, Hiroshi ; Horiguchi, Jun</creatorcontrib><description>MicroRNAs (miRNAs) are short non-coding RNAs that regulate the function of target genes at the post-transcriptional phase. miRNAs are considered to have roles in the development, progression and metastasis of cancer. Recent studies have indicated that particular miRNA signatures are correlated with tumor aggressiveness, response to drug therapy and patient outcome in breast cancer. On the other hand, in routine clinical practice, the treatment regimens for breast cancer are determined based on the intrinsic subtype of the primary tumor. Previous studies have shown that miRNA expression profiles of each intrinsic subtypes of breast cancer differ. In hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, miRNA expressions are found to be correlated with endocrine therapy resistance, progesterone receptor expression and heat shock protein activity. Some miRNAs are associated with resistance to HER2-targeted therapy and HER3 expression in HER2-positive breast cancer. In triple-negative breast cancer, miRNA expressions are found to be associated with BRCA mutations, immune system, epithelial-mesenchymal transition, cancer stem cell properties and androgen receptor expression. As it has been clarified that the expression levels and functions of miRNA differ among the various subtypes of breast cancer, and it is necessary to take account of the characteristics of each breast cancer subtype during research into the roles of miRNA in breast cancer. In addition, the discovery of the roles played by miRNAs in breast cancer might provide new opportunities for the development of novel strategies for diagnosing and treating breast cancer.</description><identifier>ISSN: 1434-5161</identifier><identifier>EISSN: 1435-232X</identifier><identifier>DOI: 10.1038/jhg.2016.89</identifier><identifier>PMID: 27439682</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>BRCA1 Protein - genetics ; Breast Neoplasms - classification ; Breast Neoplasms - genetics ; Breast Neoplasms - metabolism ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; MicroRNAs - genetics ; Mutation ; Receptor, ErbB-2 - metabolism ; Receptors, Estrogen - metabolism ; Receptors, Progesterone - metabolism</subject><ispartof>Journal of human genetics, 2017-01, Vol.62 (1), p.15-24</ispartof><rights>Copyright Nature Publishing Group Jan 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c387t-e08af1909edeb5387c4ba5d3a503ec6f0d5ecb1b31559247555bcb5ebd61db1d3</citedby><cites>FETCH-LOGICAL-c387t-e08af1909edeb5387c4ba5d3a503ec6f0d5ecb1b31559247555bcb5ebd61db1d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27439682$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kurozumi, Sasagu</creatorcontrib><creatorcontrib>Yamaguchi, Yuri</creatorcontrib><creatorcontrib>Kurosumi, Masafumi</creatorcontrib><creatorcontrib>Ohira, Miki</creatorcontrib><creatorcontrib>Matsumoto, Hiroshi</creatorcontrib><creatorcontrib>Horiguchi, Jun</creatorcontrib><title>Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes</title><title>Journal of human genetics</title><addtitle>J Hum Genet</addtitle><description>MicroRNAs (miRNAs) are short non-coding RNAs that regulate the function of target genes at the post-transcriptional phase. miRNAs are considered to have roles in the development, progression and metastasis of cancer. Recent studies have indicated that particular miRNA signatures are correlated with tumor aggressiveness, response to drug therapy and patient outcome in breast cancer. On the other hand, in routine clinical practice, the treatment regimens for breast cancer are determined based on the intrinsic subtype of the primary tumor. Previous studies have shown that miRNA expression profiles of each intrinsic subtypes of breast cancer differ. In hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, miRNA expressions are found to be correlated with endocrine therapy resistance, progesterone receptor expression and heat shock protein activity. Some miRNAs are associated with resistance to HER2-targeted therapy and HER3 expression in HER2-positive breast cancer. In triple-negative breast cancer, miRNA expressions are found to be associated with BRCA mutations, immune system, epithelial-mesenchymal transition, cancer stem cell properties and androgen receptor expression. As it has been clarified that the expression levels and functions of miRNA differ among the various subtypes of breast cancer, and it is necessary to take account of the characteristics of each breast cancer subtype during research into the roles of miRNA in breast cancer. In addition, the discovery of the roles played by miRNAs in breast cancer might provide new opportunities for the development of novel strategies for diagnosing and treating breast cancer.</description><subject>BRCA1 Protein - genetics</subject><subject>Breast Neoplasms - classification</subject><subject>Breast Neoplasms - genetics</subject><subject>Breast Neoplasms - metabolism</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>MicroRNAs - genetics</subject><subject>Mutation</subject><subject>Receptor, ErbB-2 - metabolism</subject><subject>Receptors, Estrogen - metabolism</subject><subject>Receptors, Progesterone - metabolism</subject><issn>1434-5161</issn><issn>1435-232X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqNkU1LHEEQhptgiMbklLs0eAnIrP05M30UMSYgBiSB3Ib-qMn2stu9dvUg_oP8bGfVJODJUxUvDw9UvYR84mzBmexPV8vfC8F4u-jNG3LAldSNkOLX3uOuGs1bvk_eI64YY1J04h3ZF52Spu3FAflzAx5SpbVACkhjopvoS765PqMFEGzxyzmsmboCFiv1Nnko9C7WJd3aUqOf1rbQMfsJaU60LoFaxOyjrTEnpA7qHcB_LVKbwk5ZYsLoKU6u3m8BP5C3o10jfHyeh-Tnl4sf51-bq--X387Prhov-642wHo7csMMBHB6jrxyVgdpNZPg25EFDd5xJ7nWRqhOa-280-BCy4PjQR6Sz0_ebcm3E2AdNhE9rNc2QZ5w4L02qlO90q9ARdsJqRWb0eMX6CpPJc2H7IRacm6MmKmTJ2p-BWKBcdiWuLHlfuBs2HU5zF0Ouy6H3sz00bNzchsI_9i_5ckHjS2cOg</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Kurozumi, Sasagu</creator><creator>Yamaguchi, Yuri</creator><creator>Kurosumi, Masafumi</creator><creator>Ohira, Miki</creator><creator>Matsumoto, Hiroshi</creator><creator>Horiguchi, Jun</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20170101</creationdate><title>Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes</title><author>Kurozumi, Sasagu ; Yamaguchi, Yuri ; Kurosumi, Masafumi ; Ohira, Miki ; Matsumoto, Hiroshi ; Horiguchi, Jun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c387t-e08af1909edeb5387c4ba5d3a503ec6f0d5ecb1b31559247555bcb5ebd61db1d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>BRCA1 Protein - genetics</topic><topic>Breast Neoplasms - classification</topic><topic>Breast Neoplasms - genetics</topic><topic>Breast Neoplasms - metabolism</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>MicroRNAs - genetics</topic><topic>Mutation</topic><topic>Receptor, ErbB-2 - metabolism</topic><topic>Receptors, Estrogen - metabolism</topic><topic>Receptors, Progesterone - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kurozumi, Sasagu</creatorcontrib><creatorcontrib>Yamaguchi, Yuri</creatorcontrib><creatorcontrib>Kurosumi, Masafumi</creatorcontrib><creatorcontrib>Ohira, Miki</creatorcontrib><creatorcontrib>Matsumoto, Hiroshi</creatorcontrib><creatorcontrib>Horiguchi, Jun</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of human genetics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kurozumi, Sasagu</au><au>Yamaguchi, Yuri</au><au>Kurosumi, Masafumi</au><au>Ohira, Miki</au><au>Matsumoto, Hiroshi</au><au>Horiguchi, Jun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes</atitle><jtitle>Journal of human genetics</jtitle><addtitle>J Hum Genet</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>62</volume><issue>1</issue><spage>15</spage><epage>24</epage><pages>15-24</pages><issn>1434-5161</issn><eissn>1435-232X</eissn><abstract>MicroRNAs (miRNAs) are short non-coding RNAs that regulate the function of target genes at the post-transcriptional phase. miRNAs are considered to have roles in the development, progression and metastasis of cancer. Recent studies have indicated that particular miRNA signatures are correlated with tumor aggressiveness, response to drug therapy and patient outcome in breast cancer. On the other hand, in routine clinical practice, the treatment regimens for breast cancer are determined based on the intrinsic subtype of the primary tumor. Previous studies have shown that miRNA expression profiles of each intrinsic subtypes of breast cancer differ. In hormone receptor-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer, miRNA expressions are found to be correlated with endocrine therapy resistance, progesterone receptor expression and heat shock protein activity. Some miRNAs are associated with resistance to HER2-targeted therapy and HER3 expression in HER2-positive breast cancer. In triple-negative breast cancer, miRNA expressions are found to be associated with BRCA mutations, immune system, epithelial-mesenchymal transition, cancer stem cell properties and androgen receptor expression. As it has been clarified that the expression levels and functions of miRNA differ among the various subtypes of breast cancer, and it is necessary to take account of the characteristics of each breast cancer subtype during research into the roles of miRNA in breast cancer. In addition, the discovery of the roles played by miRNAs in breast cancer might provide new opportunities for the development of novel strategies for diagnosing and treating breast cancer.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>27439682</pmid><doi>10.1038/jhg.2016.89</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1434-5161 |
ispartof | Journal of human genetics, 2017-01, Vol.62 (1), p.15-24 |
issn | 1434-5161 1435-232X |
language | eng |
recordid | cdi_proquest_miscellaneous_1859474845 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | BRCA1 Protein - genetics Breast Neoplasms - classification Breast Neoplasms - genetics Breast Neoplasms - metabolism Female Gene Expression Regulation, Neoplastic Humans MicroRNAs - genetics Mutation Receptor, ErbB-2 - metabolism Receptors, Estrogen - metabolism Receptors, Progesterone - metabolism |
title | Recent trends in microRNA research into breast cancer with particular focus on the associations between microRNAs and intrinsic subtypes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T11%3A29%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20trends%20in%20microRNA%20research%20into%20breast%20cancer%20with%20particular%20focus%20on%20the%20associations%20between%20microRNAs%20and%20intrinsic%20subtypes&rft.jtitle=Journal%20of%20human%20genetics&rft.au=Kurozumi,%20Sasagu&rft.date=2017-01-01&rft.volume=62&rft.issue=1&rft.spage=15&rft.epage=24&rft.pages=15-24&rft.issn=1434-5161&rft.eissn=1435-232X&rft_id=info:doi/10.1038/jhg.2016.89&rft_dat=%3Cproquest_cross%3E1826723540%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1855311992&rft_id=info:pmid/27439682&rfr_iscdi=true |